News

Crizanlizumab for preventing sickle cell crises in sickle cell disease

News / By

After considering the feedback from consultation, the appraisal committee has prepared a final appraisal document (FAD) on crizanlizumab for preventing sickle cell crises in sickle cell disease and submitted it to NICE. The FAD has been sent to consultees for this appraisal who have 15 working days to consider whether they wish to appeal against …

Crizanlizumab for preventing sickle cell crises in sickle cell disease Read More »

Scroll to Top